chicago  reuters    the chairman of the u s  senate judiciary committee on tuesday urged federal antitrust officials to conduct a  careful analysis  of dow chemical co s proposed   billion merger with dupont  adding pressure on officials to scrutinize how rapid consolidation in agriculture will affect farmers and consumers  u s  senator charles grassley called for the review in a letter to the u s  department of justice s antitrust division  the iowa republican said he was concerned the planned tie up will decrease competition in the farming sector following a flood of mergers and acquisitions in recent years  he also said he was worried the deal could raise barriers to entry for smaller companies  hurt innovation and raise prices for products  grassley s request for a federal review increases attention on risks of consolidation as more large agribusiness deals are in the offing  bayer ag is pursuing a   billion acquisition of monsanto co  the world s top seed maker  while chinese state owned china national chemical corp   or chemchina  plans to buy swiss crop chemicals company syngenta ag for   billion  a global downturn in grain prices and a strong dollar have reduced u s  farm income and prompted farmers to cut spending  that has eaten into sales of the big six agrochemical and seed companies that are now looking to bolster profits through mergers and partnerships  dow expects the regulatory review of its proposed merger with dupont  will be a thorough process   a company spokeswoman said  the deal is  pro competitive and good for farmers and consumers   she said  dow has previously said it expects the deal to close in the second half of   dupont had no immediate comment  the justice department declined to comment  in march  grassley  who also serves on the agriculture committee  joined other senators asking for the u s  government panel that reviews foreign acquisitions to assess the impact of chemchina s planned acquisition of syngenta on domestic food security   the u s  department of agriculture has agreed to join the review panel  people familiar with the matter have told reuters  a move that subjects the deal to additional government scrutiny  last month  monsanto turned down bayer s acquisition attempt as  incomplete and financially inadequate  but said it was open to further negotiations  monsanto said the initial offer did not adequately address potential  regulatory execution risks related to the acquisition   